NPHC OTC
Nutra Pharma Corp.
1W: +0.0%
1M: +0.0%
3M: -66.7%
YTD: -66.7%
1Y: +0.0%
3Y: -66.7%
5Y: -93.3%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$438K
+348.4% ▲
5Y CAGR: +29.4%
Gross Profit
$249K
+2841.1% ▲
5Y CAGR: +21.5%
Operating Income
-$2M
+0.7% ▲
Net Income
$8M
+162.4% ▲
EPS (Diluted)
$0.00
+122.2% ▲
EBITDA
-$2M
+85.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $131K | $104K | $52K | $98K | $438K |
| YoY Growth | +7.9% | -20.1% | -50.3% | +88.3% | +348.4% |
| Cost of Revenue | $117K | $70K | $37K | $89K | $189K |
| Gross Profit | $14K | $35K | $15K | $8K | $249K |
| Gross Margin | 10.8% | 33.3% | 28.7% | 8.7% | 56.8% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1M | $1M | $1M | $2M | $2M |
| Operating Expenses | $1M | $1M | $1M | $2M | $2M |
| Operating Income | -$2M | -$1M | -$925K | -$2M | -$2M |
| Operating Margin | -1438.7% | -1118.9% | -1782.3% | -1964.6% | -435.2% |
| Interest Expense | $590K | $262K | $336K | $496K | $791K |
| Income Before Tax | -$4M | -$7M | -$769K | -$13M | $8M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$4M | -$7M | -$769K | -$13M | $8M |
| Net Margin | -2974.6% | -6314.1% | -1482.1% | -13399.0% | 1865.7% |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $0.00 |
| EBITDA | -$3M | -$6M | -$366K | -$13M | -$2M |
| Shares Outstanding | 3.19B | 4.71B | 6.61B | 7.23B | 19.10B |